Log in to search using one of your social media accounts:

 

How DID a transplant cure this man of HIV?
Timothy Brown, the 51-year-old American man known as the 'Berlin patient', was declared HIV-free in 2008 after two bone marrow transplants at a hospital in Berlin. (Source: the Mail online | Health)
Source: the Mail online | Health - November 10, 2017 Category: Consumer Health News Source Type: news

FDA OKs drug to block infection after marrow transplant
U.S. regulators approve new drug to prevent life-threatening infections in adults after a bone marrow transplant (Source: ABC News: Health)
Source: ABC News: Health - November 8, 2017 Category: Consumer Health News Tags: Health Source Type: news

Research suggests new way to treat inflammatory gut disease and prevent rejection of bone marrow transplants
(NYU Langone Health / NYU School of Medicine) A new study explains how a widely used drug is effective against inflammatory bowel disease and rejection of bone marrow transplants, while suggesting another way to address both health issues. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - October 31, 2017 Category: Biology Source Type: news

Randomized trial to determine most effective, least toxic treatment for babies with SCID
(Children's Hospital Los Angeles) Investigators plan to determine the lowest dose of chemotherapy needed for babies with severe combined immunodeficiency undergoing bone marrow transplant. The goal is to restore the immune system safely and effectively with less toxicity than the higher dose regimens currently in use. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 5, 2017 Category: International Medicine & Public Health Source Type: news

WATCH: Robin Roberts' transplant anniversary inspires Be the Match registrations
Be the Match marrow registry broke a one-day record for online registrations after "GMA" celebrated the fifth anniversary of Roberts' lifesaving bone marrow transplant. (Source: ABC News: Health)
Source: ABC News: Health - September 22, 2017 Category: Consumer Health News Tags: GMA Source Type: news

Bone marrow program for Oishei Children's receives go-ahead from state
With the new John R. Oishei Children ’s Hospital set to open in less than two months, state officials on Wednesday approved a new pediatric bone marrow transplant program to be housed at the site. The program calls for adding the program on the 12th floor in an inpatient oncology unit to be co-managed by Roswell Park Cancer Institut e. The cancer hospital’s existing bone marrow transplant program can only treat children five years and older. Part of the $1.6 billion Kaleida Health system, the… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - September 21, 2017 Category: American Health Authors: Tracey Drury Source Type: news

Robin Roberts celebrates 5th 'birthday' of bone marrow transplant
Roberts received donor cells from her sister, Sally Ann Roberts. (Source: ABC News: Health)
Source: ABC News: Health - September 20, 2017 Category: Consumer Health News Tags: Health Source Type: news

WATCH: Robin Roberts marks milestone 'birthday': 5 years since her bone marrow transplant
Plus, Dr. Richard Besser discusses the new medical advancements that have been made over the past five years, which may offer hope to those who need a marrow transplant. (Source: ABC News: Health)
Source: ABC News: Health - September 20, 2017 Category: Consumer Health News Tags: GMA Source Type: news

FDA Grants Orphan Drug Status to Cellect's ApoGraft(TM) for Acute GvHD and Chronic GvHD
ApoGraft™ aims to solve Bone Marrow Transplantation (BMT) and other transplant rejection associated diseases Cellect's CEO, Dr. Shai Yarkoni commented "We may provide the answer to a great unmet clinical need causing severe morbidity and death in t... Regenerative Medicine, FDA Cellect Biotechnology, ApoGraft, graft versus host disease, stem cell (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 5, 2017 Category: Pharmaceuticals Source Type: news

Gamida Cell launches severe aplastic anemia trial
Gamida Cell said today that the first patient has been transplanted in a study of its CordIn product for patients with severe aplastic anemia or hypoplastic myelodysplastic syndrome. The product is designed for patients with rare genetic diseases who have no fully-matched donors for a bone marrow transplantation. Gamida Cell said it is also evaluating its CordIn therapy for patients with sickle cell disease. Get the full story at our sister site, Drug Delivery Business News.   The post Gamida Cell launches severe aplastic anemia trial appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - August 21, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Research & Development Stem Cells Gamida Cell Source Type: news

Baby goes home after bone marrow transplant, 100-plus day hospital stay
Seven-month-old Denniya Rawls was treated for a life-threatening disorder. (Source: ABC News: Health)
Source: ABC News: Health - July 15, 2017 Category: Consumer Health News Tags: Health Source Type: news

WATCH: Baby leaves hospital after over 100-day stay
Denniya Rawls, 7 months old, underwent a lifesaving bone marrow transplant at Cleveland Clinic Children's in Cleveland, Ohio. (Source: ABC News: Health)
Source: ABC News: Health - July 14, 2017 Category: Consumer Health News Tags: Lifestyle Source Type: news

Two life-threatening conditions.One remarkable wish.
When Lucas St. Onge blew out the five candles on his birthday cake, he made just one wish. He didn’t ask for ninja turtles, a T-ball set or an Xbox — the only thing he wished was to be just like any other kid. “It was a gift I couldn’t give,” says his mom, Heather. On that same day, last May, he got his wish. “He got a liver, stomach, pancreas, intestine and spleen — the five organs he needed to help him become healthy and happy,” Heather says. Heather was 18 weeks pregnant when she and her husband, Anthony, learned they were about to face a myriad of medical challe...
Source: Thrive, Children's Hospital Boston - June 28, 2017 Category: Pediatrics Authors: Emily Williams Tags: Our Patients’ Stories bone marrow transplant Dana-Farber/Boston Children's Cancer and Blood Disorders Center Dr. Heung-Bae Kim Dr. Khashavar Vakili Dr. Rima Fawaz Intestine and Multivisceral Transplant Program Pediatric Transplant Center ( Source Type: news

David Loeb, M.D., PH.D., Named Chief of Pediatric Hematology-Oncology at the Children ’s Hospital at Montefiore and Albert Einstein College of Medicine
June 26, 2017—(BRONX, NY)—Leading pediatric oncologist and NIH-funded researcher David M. Loeb, M.D., Ph.D., has been named chief of the division of pediatric hematology, oncology, marrow and blood cell transplantation atAlbert Einstein College of Medicine and theChildren’s Hospital at Montefiore (CHAM). A noted sarcoma researcher and clinician and bone marrow transplantation specialist, Dr. Loeb will join the faculty on September 1, 2017. (Source: Einstein News)
Source: Einstein News - June 26, 2017 Category: Universities & Medical Training Source Type: news

David Loeb, M.D., Ph.D., Named Chief of Pediatric Hematology-Oncology at the Children ’s Hospital at Montefiore and Albert Einstein College of Medicine
June 26, 2017—(BRONX, NY)—Leading pediatric oncologist and NIH-funded researcher David M. Loeb, M.D., Ph.D., has been named chief of the division of pediatric hematology, oncology, marrow and blood cell transplantation atAlbert Einstein College of Medicine and theChildren’s Hospital at Montefiore (CHAM). A noted sarcoma researcher and clinician and bone marrow transplantation specialist, Dr. Loeb will join the faculty on September 1, 2017. (Source: Einstein News)
Source: Einstein News - June 26, 2017 Category: Universities & Medical Training Source Type: news

David Loeb, M.D., Ph.D., Named Chief of Pediatric Hematology-Oncology at the Children's Hospital at Montefiore and Albert Einstein College of Medicine
June 26, 2017—(BRONX, NY)—Leading pediatric oncologist and NIH-funded researcher David M. Loeb, M.D., Ph.D., has been named chief of the division of pediatric hematology, oncology, marrow and blood cell transplantation atAlbert Einstein College of Medicine and theChildren’s Hospital at Montefiore (CHAM). A noted sarcoma researcher and clinician and bone marrow transplantation specialist, Dr. Loeb will join the faculty on September 1, 2017. (Source: Einstein News)
Source: Einstein News - June 26, 2017 Category: Universities & Medical Training Source Type: news

An LAPD officer needs a bone marrow transplant. His ethnicity limits his chances of getting one
Matthew Medina, 40, suffers from an often-fatal disease. As a Filipino, his chances of finding a bone marrow donor are less than 50%. (Source: L.A. Times - Health)
Source: L.A. Times - Health - June 22, 2017 Category: Consumer Health News Authors: Soumya Karlamangla Source Type: news

Israel's Gamida Cell Raises $40 Mln for Bone Marrow Trial Israel's Gamida Cell Raises $40 Mln for Bone Marrow Trial
Israel's Gamida Cell, which is developing cellular therapies to treat cancer and rare genetic diseases, said on Monday it raised $40 million to finance the advanced trial of its product NiCord to facilitate bone marrow transplants.Reuters Health Information (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - June 20, 2017 Category: Transplant Surgery Tags: Transplantation News Source Type: news

Israel's Gamida Cell raises $40 million for bone marrow trial
TEL AVIV (Reuters) - Israel's Gamida Cell, which is developing cellular therapies to treat cancer and rare genetic diseases, said on Monday it raised $40 million to finance the advanced trial of its product NiCord to facilitate bone marrow transplants. (Source: Reuters: Health)
Source: Reuters: Health - June 19, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Big Slick: Three more celebrities join star-studded fundraiser
James Marsden, Samm Levine and Blake Vogt will join the star-studded lineup for Children ’s Mercy’s annual Big Slick fundraiser. The annual celebrity weekend, hosted by Kansas City comedians Rob Riggle, Paul Rudd, Jason Sudeikis, David Koechner and Eric Stonestreet will return June 23 and 24. The event has raised more than $4.5 million for Children’s Mercy since its inception sev en years ago to further pediatric cancer research, early detection and the hospital’s bone marrow transplant unit. This… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 9, 2017 Category: Pharmaceuticals Authors: Elise Reuter Source Type: news

Gut Bugs Signal Success of Bone Marrow Transplant (CME/CE)
(MedPage Today) -- Intestinal flora may serve as biomarkers for better survival (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - May 24, 2017 Category: Hematology Source Type: news

South Africa: Athlone Mom Starts Fund for Son's Marrow Transplant
[News24Wire] A Cape Town woman has launched a crowd-funding campaign to help her little boy get a bone marrow transplant overseas, after a local match was not found. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 20, 2017 Category: African Health Source Type: news

Engineered tissue could eliminate radiation for bone marrow transplants
Engineered bone with functional marrow. [Image courtesy Varghese lab, UC San Diego]University of California San Diego engineers have created artificial bone tissue that could eliminate the need for radiation before bone marrow transplants. Shyni Varghese, a bioengineering professor at UC San Diego Jacobs School of Engineering, led a team to develop a bone-like implant to eliminate the pre-treatment radiation that kills stem cells in a patient’s bone marrow to make room for new marrow. The newly engineered bone tissues give donor cells space room to live and grow without having to compete with pre-existing host c...
Source: Mass Device - May 15, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: Research & Development Stem Cells Transplants bone marrow bone marrow disease MedTech University of California San Diego Source Type: news

New finding affecting immune reconstitution related to B cells
Researchers examined the mechanisms of B cell immune reconstitution in pediatric patients who had undergone bone marrow transplantation and discovered a disruption in the maturation of B cells -- critical to the immune system -- preventing the production of antibodies that fight infection. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - May 15, 2017 Category: Science Source Type: news

New finding affecting immune reconstitution related to B cells
(Children's Hospital Los Angeles) Researchers from the Children's Center for Cancer and Blood Diseases at Children's Hospital Los Angeles examined the mechanisms of B cell immune reconstitution in pediatric patients who had undergone bone marrow transplantation and discovered a disruption in the maturation of B cells -- critical to the immune system -- preventing the production of antibodies that fight infection. The results of the study were published in the journal Biology of Blood and Marrow Transplantation on May 12. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 15, 2017 Category: Cancer & Oncology Source Type: news

Bone marrow transplants could prevent heart diesease
Researchers from Duke University found stem cell therapy significantly improves exercise time and reduces mortality in people suffering from severe chest pain, known as angina. (Source: the Mail online | Health)
Source: the Mail online | Health - May 11, 2017 Category: Consumer Health News Source Type: news

Uganda: Bone Marrow Transplant Will Save Two Brothers
[Monitor] Lucas and Louis Masiga look playful in just about every photograph their parents proudly show off. Awesome and loving boys is how their mother Juliet Masiga describes them. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 3, 2017 Category: African Health Source Type: news

Moffitt Cancer Center signs partnership with Memorial Healthcare System
Memorial Healthcare System signed an agreement with Moffitt Cancer Center, the state ’s second-largest cancer center, to bring its services to the public Broward County hospitals. Tampa-based Moffitt will employ five physicians and advanced medical practice professionals, including five nurses, to staff new programs for blood and bone marrow transplantation, and malignant hematol ogy at MHS hospitals. The program will start July 1. MHS will reimburse Moffitt for the cost of their employees working… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - May 1, 2017 Category: American Health Authors: Brian Bandell Source Type: news

Memorial Healthcare System signs partnership with Moffitt Cancer Center
Memorial Healthcare System signed an agreement with Moffitt Cancer Center, the state ’s second-largest cancer center, to bring its services to the public Broward County hospitals. Tampa-based Moffitt will employ five physicians and advanced medical practice professionals, including five nurses, to staff new programs for blood and bone marrow transplantation, and malignant hematol ogy at MHS hospitals. The program will start July 1. MHS will reimburse Moffitt for the cost of their employees working… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - May 1, 2017 Category: Health Management Authors: Brian Bandell Source Type: news

Ryan Gibson Foundation Gives $500K to the Arkansas Children's Research Institute
The Ryan Gibson Foundation of Dallas awarded on Friday $500,000 for cancer research in the new precision medicine program at Arkansas Children’s Research Institute. "Precision medicine uses information from a given to design a medical plan for an individual based on his or her environment, lifestyle, health condition and genetic makeup," Greg Kearns, president of the Arkansas Children's Research Institute, said in a news release. "The goal of precision cancer medicine in conditions such as cancer is to customize treatments by tailoring them to the genetic characteristics of not only a patient but in so...
Source: Arkansas Business - Health Care - April 14, 2017 Category: American Health Source Type: news

Pioneering stem cell gene therapy cures infants with bubble baby disease
FINDINGSUCLA researchers have developed a stem cell gene therapy cure for babies born with adenosine deaminase-deficient severe combined immunodeficiency, a rare and life-threatening condition that can be fatal within the first year of life if left untreated.In a phase 2 clinical trial led by Dr. Donald Kohn of the  Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA, all nine babies were cured. A 10th trial participant was a teenager at the time of treatment and showed no signs of immune system recovery. Kohn’s treatment method, a stem cell gene therapy that safely restores ...
Source: UCLA Newsroom: Health Sciences - March 27, 2017 Category: Universities & Medical Training Source Type: news

Gamida Cell wins additional EMA orphan drug designation for NiCord
Gamida Cell said today that the European Medicines Agency granted its NiCord cell graft an additional orphan drug designation as a treatment for hematopoietic stem cell transplantation, or bone marrow transplantation. The treatment is a graft derived from umbilical cord blood which has been expanded and enriched with stem and progenitor cells, according to the company. The EMA previously granted orphan drug designation to NiCord for acute myeloid leukemia. Get the full story at our sister site, Drug Delivery Business News. The post Gamida Cell wins additional EMA orphan drug designation for NiCord appeared first ...
Source: Mass Device - March 23, 2017 Category: Medical Equipment Authors: Sarah Faulkner Tags: Oncology Regulatory/Clearance Stem Cells Wall Street Beat Gamida Cell Source Type: news

The stem cell therapy that could reverse hearing loss
Frequency Therapeutics is betting that it can change the lives of millions of Americans with hearing loss, by triggering the body’s natural ability to heal itself. Researchers have used cells in regenerative medicine for decades – in 1931, the father of cell therapy, Paul Niehans, treated a patient with material from calf embryos. Although today’s healthcare practitioners have left bovine embryonic cells behind, procedures such as bone marrow transplants are routinely used to replenish a patient’s cells after they’ve been destroyed. When scientists first derived stem cells in 1981 – a de...
Source: Mass Device - March 23, 2017 Category: Medical Equipment Authors: Sarah Faulkner Tags: Stem Cells Wall Street Beat Frequency Therapeutics Source Type: news

Genetic Variations Linked to Post-Transplant Outcomes in Leukemia Patients
This video examines research that found that certain genetic variations of both leukemia patients undergoing bone marrow transplant and their unrelated donors were associated with poor outcomes. (Source: CancerNetwork)
Source: CancerNetwork - March 23, 2017 Category: Cancer & Oncology Authors: Theresa Hahn, PhD Tags: Videos Hematologic Malignancies Source Type: news

Common Cold Can Be Dangerous After Bone Marrow Transplant
Rhinovirus far more worrisome in those with weakened immune systems, researchers say Source: HealthDay Related MedlinePlus Pages: Bone Marrow Transplantation, Common Cold (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - March 21, 2017 Category: Consumer Health News Source Type: news

Common Cold Can Be Dangerous After Bone Marrow Transplant
TUESDAY, March 21, 2017 -- The common cold can be deadly for patients recovering from bone marrow transplants, a new study warns. After a bone marrow transplant, patients have weakened immune systems. This puts them at risk for infections that... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 21, 2017 Category: Journals (General) Source Type: news

Common Cold Can Be Dangerous After Bone Marrow Transplant
Rhinovirus far more worrisome in those with weakened immune systems, researchers say (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - March 20, 2017 Category: Respiratory Medicine Authors: webmaster at doctorslounge.com Tags: Family Medicine, Infections, Nursing, Pulmonology, Research, Immunology, News, Source Type: news

Rare cancer sufferer Daryl Allinson saved by crowdfunders
Daryl Allinson, 13, from Frome, Somerset, was struck down with a strain of leukaemia in 2015 but went into remission thanks to a bone marrow transplant from his brother. (Source: the Mail online | Health)
Source: the Mail online | Health - March 6, 2017 Category: Consumer Health News Source Type: news

Gamida Cell touts first patient treated in Phase III NiCord trial
Gamida Cell said today that the 1st patient has been treated in the Phase III registration trial of its NiCord cell graft for patients with blood cancer. The treatment is a graft derived from umbilical cord blood which has been expanded and enriched with stem and progenitor cells, according to the company. The Jerusalem-based company’s cell graft was designed as an alternative to bone marrow transplantation for patients with blood cancer who do not have a fully matched donor. Get the full story at our sister site, Drug Delivery Business News. The post Gamida Cell touts first patient treated in Phase III NiC...
Source: Mass Device - February 28, 2017 Category: Medical Equipment Authors: Sarah Faulkner Tags: Clinical Trials Food & Drug Administration (FDA) Oncology Research & Development Gamida Cell Source Type: news

Merck ’s letermovir meets primary endpoint in Phase III trial to prevent CMV infection
Healthcare firm Merck has reported positive results from the Phase III clinical trial of anti-viral drug letermovir to prevent cytomegalovirus (CMV) infection in recipients of bone marrow transplant. (Source: Drug Development Technology)
Source: Drug Development Technology - February 28, 2017 Category: Pharmaceuticals Source Type: news

Merck ’s Letermovir, an Investigational Antiviral Medicine for Prevention of Cytomegalovirus (CMV) Infection in Bone Marrow Transplant Recipients, Highly Effective Through Week 24 Post-Transplant in Pivotal Phase 3 Study
Dateline City: KENILWORTH, N.J. Letermovir Prophylaxis Associated with Lower All-Cause Mortality Through Week 24 Post-Transplant Company Plans to Submit New Drug Applications for Letermovir in U.S. and EU in 2017KENILWORTH, N.J.--(BUSINESS WIRE)--Merck& Co., Inc. (NYSE:MRK), known as MSD outside the United States and Canada, today announced results of the pivotal Phase 3 clinical study of letermovir, an investigational antiviral medicine for the prevention of clinically-significant cytomegalovirus (CMV) infection in adult (18 years and older) CMV-seropositive recipients of an allogeneic hematopo...
Source: Merck.com - Research and Development News - February 26, 2017 Category: Pharmaceuticals Tags: Research and Development News Corporate News Latest News #Merck #MRK $MRK Letermovir MSD NYSE:MRK Source Type: news

Merck drug prevents serious infection after marrow transplant: study
(Reuters) - An experimental Merck& Co drug succeeded in preventing clinically serious cytomegalovirus (CMV) following bone marrow transplant and was associated with a lower death rate compared with placebo in a late state study, the company said. (Source: Reuters: Health)
Source: Reuters: Health - February 23, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

43rd Annual Meeting of the European Society for Blood and Marrow Transplantation
(European Society for Blood and Marrow Transplantation) During its 43rd Annual Meeting, the EBMT will acknowledge the work that stems from the pioneering observations made by E. Donnall Thomas, also known as the father of bone marrow transplantation. At the Opening Session, Rainer Storb from the faculty of both, the Fred Hutchinson Cancer Research Center and the University of Washington School of Medicine, will give a keynote lecture entitled, '60 years of HSCT: progress from bone marrow transplantation to the first cellular and gene therapies.' (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 23, 2017 Category: Cancer & Oncology Source Type: news

Toddler with leukaemia is saved by designer immune cells
One-year-old Layla was diagnosed when she was just 14 weeks old. Chemotherapy and bone marrow transplant failed to halt the aggressive disease. She was taken to Great Ormond Street. (Source: the Mail online | Health)
Source: the Mail online | Health - February 19, 2017 Category: Consumer Health News Source Type: news

A 60-Year-Old Man With Progressive Anemia While Receiving Checkpoint Blockade Therapy for Relapsed Myelofibrosis
A 60-year-old man with a history of coronary artery disease and JAK2 V617F –positive polycythemia vera presented to our bone marrow transplantation clinic with progressive fatigue, splenomegaly, and cytopenias. (Source: CancerNetwork)
Source: CancerNetwork - February 15, 2017 Category: Cancer & Oncology Authors: Aaron M. Goodman, MD Caitlin Costello, MD Edward D. Ball, MD Megan Rust, MD Tags: Case Studies Hematologic Malignancies Oncology Journal Source Type: news

Algorithm Predicts Severe GVHD After Bone Marrow Transplant Algorithm Predicts Severe GVHD After Bone Marrow Transplant
A blood test performed 7 days after bone marrow transplant may predict serious, life-threatening GVHD and allow early intervention.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 9, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Doctors create 'MAGIC algorithm' to predict bone marrow transplant patients' risk of dying
(The Mount Sinai Hospital / Mount Sinai School of Medicine) Researchers at Mount Sinai Health System have discovered a way to predict whether blood cancer patients who received a bone marrow transplant will develop graft-versus-host disease, a common and often lethal complication, according to a study published in JCI (The Journal of Clinical Investigation) Insight. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 9, 2017 Category: Cancer & Oncology Source Type: news

Sixteen aplastic anemia patients free of disease after bone marrow transplant and chemo
Physicians report they have successfully treated 16 patients with a rare and lethal form of bone marrow failure called severe aplastic anemia using partially matched bone marrow transplants followed by two high doses of a common chemotherapy drug. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 7, 2017 Category: Science Source Type: news

16 aplastic anemia patients free of disease after bone marrow transplant and chemo
(Johns Hopkins Medicine) Physicians at the Johns Hopkins Kimmel Cancer Center report they have successfully treated 16 patients with a rare and lethal form of bone marrow failure called severe aplastic anemia using partially matched bone marrow transplants followed by two high doses of a common chemotherapy drug. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 7, 2017 Category: Cancer & Oncology Source Type: news